Article

Sulfonylurea monotherapy ups CVD risk vs. metformin in older diabetics

Older patients started on oral antidiabetic therapy with a sulfonylurea have significantly higher risk for cardiovascular disease (CVD) events than patients started on metformin.

Newsletter

Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.

Subscribe Now!
Related Videos
Martin Burns of Bruin Biometrics
Martin Burns of Bruin Biometrics
Martin Burns of Bruin Biometrics
Related Content
Group coaching cuts physician burnout by nearly 30% in UCLA study © studio romantic - stock.adobe.com
July 11th 2025

Group coaching cuts physician burnout nearly 30% in UCLA study

Off the Chart: A Business of Medicine Podcast - Ep. 72: Medicare reform with Susan Dentzer of America's Physician Groups
July 7th 2025

Ep. 72: Medicare reform with Susan Dentzer of America's Physician Groups

fda approved stamp: © Olivier Le Moal - stock.adobe.com
July 11th 2025

FDA leader touts achievements of first 100 days; NIH will cap publishing fees while disseminating research results

Off the Chart: A Business of Medicine Podcast - Ep. 71: Agentic AI with Isaac Park of Keebler Health
June 30th 2025

Ep. 71: Agentic AI with Isaac Park of Keebler Health

Morning Medical Update © Dz Lab - stock.adobe.com
July 11th 2025

CVS’ Omnicare unit ordered to pay $949M in whistleblower fraud case; workplace mental health at risk; new AI tool outperforms Big Tech in reading chest X-rays – Morning Medical Update

primary care word cloud: © ibreakstock - stock.adobe.com
July 10th 2025

Optum, other health insurers are gaining more and more control of primary care across the country: study